Processing

Please wait...

Settings

Settings

Goto Application

1. WO2017174593 - NOVEL ANTIVIRAL COMPOSITIONS FOR THE TREATMENT OF INFLUENZA

Publication Number WO/2017/174593
Publication Date 12.10.2017
International Application No. PCT/EP2017/058009
International Filing Date 04.04.2017
IPC
A61K 31/635 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
63Compounds containing para-N-benzene- sulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonohydrazide
635having a heterocyclic ring, e.g. sulfadiazine
A61K 31/7048 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7048having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61P 31/16 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
16for influenza or rhinoviruses
CPC
A61K 31/635
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
635having a heterocyclic ring, e.g. sulfadiazine
A61K 31/7048
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7048having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin ; digitoxin or digoxin
A61P 31/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
A61P 31/16
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
12Antivirals
14for RNA viruses
16for influenza or rhinoviruses
Applicants
  • UNIVERSITE CLAUDE BERNARD LYON 1 [FR]/[FR]
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) [FR]/[FR]
  • HOSPICES CIVILS DE LYON [FR]/[FR]
  • UNIVERSITE LAVAL [CA]/[CA]
Inventors
  • ROSA-CALATRAVA, Manuel
  • TERRIER, Olivier
  • PIZZORNO, Mario
  • BOIVIN, Guy
  • PADEY, Blandine
  • TEXTORIS, Julien
Agents
  • REGIMBEAU
Priority Data
165305707.04.2016FR
Publication Language French (FR)
Filing Language French (FR)
Designated States
Title
(EN) NOVEL ANTIVIRAL COMPOSITIONS FOR THE TREATMENT OF INFLUENZA
(FR) NOUVELLES COMPOSITIONS ANTIVIRALES POUR LE TRAITEMENT DE LA GRIPPE
Abstract
(EN)
The invention relates to a veterinary or pharmaceutical composition for use in the prevention and/or treatment of an infection from at least one influenza virus, characterised in that it comprises, in a suitable pharmaceutical carrier, at least one antiviral compound selected from roxithromycin and sulfadimethoxine.
(FR)
La présente invention concerne une composition pharmaceutique ou vétérinaire pour son utilisation dans la prévention et/ou le traitement d'une infection par au moins un virus influenza, caractérisée en ce qu'elle comprend, dans un véhicule pharmaceutique approprié, au moins un composé antiviral choisi parmi la Roxithromycine et la Sulfadimethoxine.
Latest bibliographic data on file with the International Bureau